tiprankstipranks
Trending News
More News >

Andrew Krakauer Insider Profile

4 Followers
Andrew Krakauer, CEO, Director at Cantel Medical, holds 7.19K shares in Teleflex (Ticker: TFX), holds 143.34K shares in Cantel Medical (Ticker: CMD). Most recently, Andrew Krakauer Bought ― shares of Teleflex on Aug 07, 2025 for an estimated value of $115.25K.
tipranks
Andrew Krakauer

Andrew Krakauer
Cantel Medical (CMD)
CEO, Director

Ranked #86,344 out of 103,104 Corporate Insiders

Profitable Transactions

25%
2 out of 8 Profitable Transactions

Average Return

-19.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$868K
100.00%
A breakdown of Andrew Krakauer's holdings

Insider Roles

Teleflex
(TFX)
Director
Roles that Andrew Krakauer holds in companies

Most Profitable Insider Trade

Stock:
Teleflex
(TFX)
Rating:Informative Buy
Date:Aug 08, 2018 - Aug 08, 2019
Return:+58.30%
The most profitable trade made by Andrew Krakauer

Andrew Krakauer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CMD
Cantel Medical
Dec 30, 2015
Informative Sell
589.78K
$11.52M
Teleflex
Aug 07, 2025
Director
Informative Buy
115.25K
$867.93K
List of latest transactions for each holding click on a transaction to see Andrew Krakauer's performance on stock

Andrew Krakauer insider profile FAQ

What is the percentage of profitable transactions made by Andrew Krakauer?
The percentage of profitable transactions made by Andrew Krakauer is 25%.
    What is the average return per transaction made by Andrew Krakauer?
    The average return per transaction made by Andrew Krakauer is -19.70%.
      What stocks does Andrew Krakauer hold?
      Andrew Krakauer holds: CMD, TFX stocks.
        What was Andrew Krakauer’s latest transaction?
        Andrew Krakauer latest transaction was an Informative Buy of $115.25K.
          What was Andrew Krakauer's most profitable transaction?
          Andrew Krakauer’s most profitable transaction was an Informative Buy of TFX stock on August 8, 2018. The return on the trade was 58.30%.
            What is Andrew Krakauer's role in Cantel Medical?
            Andrew Krakauer's role in Cantel Medical is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.